Andrea Harzstark
- Oncology top 5%
- Cancer Treatment and Pharmacology 15
- Cancer Immunotherapy and Biomarkers 8
-
- Prostate Cancer Treatment and Research 35
- Renal cell carcinoma treatment 13
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 6
- Immunology top 5%
- Molecular Biology top 10%
- Renal and related cancers 8
-
- Radiopharmaceutical Chemistry and Applications 18
-
- Multiple Myeloma Research and Treatments 6
Andrea Harzstark
58 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 894
- Pulmonary and Respiratory Medicine 997
- Cancer Research 376
- Immunology 435
- Molecular Biology 811
Countries citing papers authored by Andrea Harzstark
This map shows the geographic impact of Andrea Harzstark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Harzstark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Harzstark more than expected).
Fields of papers citing papers by Andrea Harzstark
This network shows the impact of papers produced by Andrea Harzstark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Harzstark. The network helps show where Andrea Harzstark may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Harzstark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 30 | |
| 5 | 2017 | 8 | |
| 6 | 2016 | 4 | |
| 7 | 2015 | 50 | |
| 8 | 2014 | 31 | |
| 9 | 2014 | 49 | |
| 10 | 2014 | 31 | |
| 11 | 2013 | 103 | |
| 12 | 2013 | 311 | |
| 13 | Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studybreakdown → | 2013 | 436 |
| 14 | 2013 | 36 | |
| 15 | 2013 | 326 | |
| 16 | 2011 | 47 | |
| 17 | 2011 | 3 | |
| 18 | 2010 | 15 | |
| 19 | 2010 | 18 | |
| 20 | 2007 | 11 |
About Andrea Harzstark
Andrea Harzstark is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 61 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (35 papers), Radiopharmaceutical Chemistry and Applications (18 papers), Cancer Treatment and Pharmacology (15 papers), Renal cell carcinoma treatment (13 papers), Renal and related cancers (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Cancer, Lipids, and Metabolism (6 papers). The work is most often cited by research in Oncology (894 citations), Pulmonary and Respiratory Medicine (997 citations) and Cancer Research (376 citations). Andrea Harzstark has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Eric J. Small, Charles J. Ryan, Tomasz M. Beer, Celestia S. Higano, Howard I. Scher, Sheela Tejwani, Susan F. Slovin, Omid Hamid, Kevin M. Chin and M. Brent McHenry. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.